Free Trial

Stock Traders Buy High Volume of Call Options on Calumet Specialty Products Partners (NASDAQ:CLMT)

Calumet Specialty Products Partners logo with Energy background

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) was the target of some unusual options trading on Friday. Stock traders acquired 9,051 call options on the stock. This is an increase of 78% compared to the average volume of 5,083 call options.

Calumet Specialty Products Partners Stock Performance

CLMT traded up $0.96 during trading on Friday, reaching $15.13. 2,463,086 shares of the stock were exchanged, compared to its average volume of 954,486. Calumet Specialty Products Partners has a twelve month low of $7.68 and a twelve month high of $25.29. The stock has a market cap of $1.30 billion, a P/E ratio of -5.48 and a beta of 0.91. The stock's 50 day moving average price is $12.09 and its two-hundred day moving average price is $15.32.

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last issued its quarterly earnings results on Friday, May 9th. The oil and gas company reported ($1.03) EPS for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.62). The business had revenue of $993.90 million for the quarter, compared to analyst estimates of $899.62 million. The company's revenue was down 1.2% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.51) earnings per share. Equities research analysts predict that Calumet Specialty Products Partners will post -3.02 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

CLMT has been the subject of several recent research reports. Wells Fargo & Company dropped their price target on Calumet Specialty Products Partners from $23.00 to $21.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. TD Cowen lowered shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and lowered their target price for the stock from $26.00 to $16.00 in a research note on Tuesday, March 4th. Bank of America initiated coverage on shares of Calumet Specialty Products Partners in a research note on Tuesday, May 13th. They issued a "buy" rating and a $15.00 target price on the stock. UBS Group raised Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and cut their target price for the company from $15.00 to $12.00 in a research report on Monday, March 17th. Finally, The Goldman Sachs Group lowered their target price on shares of Calumet Specialty Products Partners from $16.00 to $14.00 and set a "buy" rating for the company in a research note on Wednesday, April 30th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $18.50.

Check Out Our Latest Stock Report on Calumet Specialty Products Partners

Insider Activity at Calumet Specialty Products Partners

In other news, Director Stephen P. Mawer sold 3,655 shares of the business's stock in a transaction dated Tuesday, April 22nd. The stock was sold at an average price of $9.29, for a total value of $33,954.95. Following the completion of the sale, the director now owns 283,652 shares of the company's stock, valued at approximately $2,635,127.08. The trade was a 1.27% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jennifer Straumins sold 100,000 shares of the stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $13.17, for a total value of $1,317,000.00. Following the completion of the transaction, the director now directly owns 1,084,589 shares of the company's stock, valued at $14,284,037.13. This represents a 8.44% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 107,310 shares of company stock valued at $1,398,031 over the last ninety days. 4.07% of the stock is owned by corporate insiders.

About Calumet Specialty Products Partners

(Get Free Report)

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

Read More

Should You Invest $1,000 in Calumet Specialty Products Partners Right Now?

Before you consider Calumet Specialty Products Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.

While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines